RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MASSAIA M
Collezione AO Cuneo

Items : 41

Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi. in Hematological oncology / Hematol Oncol. 2023 Oct;41(4):655-662. doi: 10.1002/hon.3184. Epub 2023 May 28.

2023
AO Cuneo
ASL Biella

Gini G; Federico M; Luminari S; Marcheselli L; Catellani H; Skrypets T; Stefani PM; Pastore D; Pennese E; Liberati AM; Ballerini F; Vitolo U; Usai SV; Capponi M; Galimberti S; Perrone T; Re F; Mannina D; Musto P; Conconi A; Bari A; Massaia M; Ghiggi C; Pulsoni A; Musuraca G; Califano C; Merli M; Manni M; Nizzoli ME; et alii...

SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia. in British journal of haematology / Br J Haematol. 2023 May;201(3):411-416. doi: 10.1111/bjh.18606. Epub 2022 Dec 20.

2023
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Alessandria
AOU Novara

Tiacci E; Corradini P; Pulsoni A; Rivela P; Bertù L; Falini B; Massaia M; Della Porta MG; Busca A; Vallisa D; Cattaneo C; Bruna R; Tisi MC; Selleri C; Capponi M; De Carolis L; Gozzetti A; Broccoli A; Romano A; D'Elia GM; Candoni A; Morotti A; Mancini A; Marchetti M; Passamonti F;

Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review. in Journal of clinical medicine / J Clin Med. 2023 Jul 10;12(14):4590. doi: 10.3390/jcm12144590.

2023
AO Cuneo
AOU Città della Salute di Torino

Bruno B; Borchiellini A; Porreca A; Grimaldi D; Massaia M; Valpreda A; Dainese C; Valeri F; Bardetta M; Sella C;

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.

2023
ASL Torino 5
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara

Coviello E; Cilloni D; Passamonti F; Corradini P; Bertù L; Guidetti A; Visco C; Pagano L; Gherlinzoni F; Galimberti S; Tisi MC; Cudillo L; Gentile M; Mohamed S; Visani G; Federici AB; Della Porta MG; Mauro FR; Gambacorti-Passerini C; Massaia M; Bocchia M; Scattolin A; Billio A; Marchesi F; Trentin L; Cattaneo C; Derenzini E; Fracchiolla NS; Romano A; et alii...

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
ASL Cuneo 1
AOU Novara

Fazi P; Vignetti M; Piciocchi A; Cuneo A; Foà R; Guarini A; Nanni M; Neri A; De Propris MS; De Novi LA; Visentin A; Vitale C; Albano F; Molinari MC; Pietrasanta D; Mattiello V; Liberati AM; Giordano A; Gottardi D; Patrizi VB; Galieni P; Musuraca G; Deodato M; Arcari A; Tani M; Levato L; Marchetti M; Massaia M; Rigolin GM; et alii...

V?9V?2 T-cell immunotherapy in blood cancers: ready for prime time? in Frontiers in immunology / Front Immunol. 2023 Apr 18;14:1167443. doi: 10.3389/fimmu.2023.1167443. eCollection 2023.

2023
AO Cuneo

Giannotta C; Autino F; Massaia M;

Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients. in British journal of haematology / Br J Haematol. 2022 Nov;199(3):463-467. doi: 10.1111/bjh.18429. Epub 2022 Sep 5.

2022
AO Cuneo
ASL Cuneo 1
AOU Alessandria

Gariglio M; Gaidano G; Ladetto M; Massaia M; Lai M; Pistello M; Rapezzi D; Marchetti M; Gaidano V; Mahmoud AM; Ucciero MAM; Patriarca A; Ferrante D; Griffante G; Martuscelli L; De Andrea M; Borgogna C; Bruna R;

ADAMTS13 Autoantibodies and Burden of Care in Immune Thrombotic Thrombocytopenic purpura: New Evidence and Future Implications. in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis / Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221125785. doi: 10.1177/10760296221125785.

2022
AOU Città della Salute di Torino
AO Cuneo
AO Ordine Mauriziano

Borchiellini A; Pizzo E; Valpreda A; Sivera P; Montaruli B; Porreca A; Massaia M; Bruno B; Dainese C; Valeri F;

Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients. in Blood cancer journal / Blood Cancer J. 2022 Jan 18;12(1):8. doi: 10.1038/s41408-022-00608-6.

2022
ASL Cuneo 1
AO Cuneo
AOU Alessandria

Gaidano G; Lai M; Pistello M; Rapezzi D; Massaia M; Gariglio M; Ladetto M; Gaidano V; Marchetti M; Mahmoud AM; Patriarca A; Griffante G; Martuscelli L; De Andrea M; Ferrante D; Borgogna C; Bruna R;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
ASL Torino 5
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
AOU Alessandria

Ladetto M; Pilerci S; Pinto A; Ramadan S; Marchesi F; Cavo M; Musto P; Coviello E; Romano A; Passamonti F; Corradini P; Krampera M; Tosi P; Lanza F; Candoni A; Selleri C; Conconi A; Visani G; Vallisa D; Venditti A; Gambacorti-Passerini C; Rigacci L; La Barbera EO; Corso A; Armiento D; Cilloni D; Cardinali V; Galimberti S; Bocchia M; et alii...

Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):857-863. doi: 10.1002/hon.3060. Epub 2022 Aug 14.

2022
ASL Cuneo 1
ASL Città di Torino
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria

Passamonti F; Corradini P; Fabbri E; Coviello E; Ruggeri M; Ferrero D; Venditti A; Romano I; Gentile M; Mecucci C; Gherlinzoni F; Mohamed S; Krampera M; Marchetti M; Massaia M; Arcaini L; Sacchi MV; Guidetti A; Ciceri F; Cairoli R; Monaco F; Lanza F;

Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):846-856. doi: 10.1002/hon.3048. Epub 2022 Aug 12.

2022
AO Cuneo
ASL Torino 5
AOU Città della Salute di Torino

Passamonti F; Arcaini L; Bruno R; Antonio Grossi P; Corradini P; Pagano L; Busca A; Giuliani N; Luppi M; Tosi P; Mohamed S; Corso A; Rigacci L; Giovanni Della Porta M; Lanza F; Venditti A; Massimo Lemoli R; Billio A; Gentile M; Falini B; Turrini M; Tafuri A; Morotti A; Chiara Tisi M; Galimberti S; Coviello E; Trentin L; Cuneo A; Bocchia M; et alii...

How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2022 Aug;63(8):1985-1988. doi: 10.1080/10428194.2022.2053532. Epub 2022 Mar 27.

2022
AO Cuneo
AOU Città della Salute di Torino

Tedeschi A; Ferrario A; Montillo M; Zamprogna G; Marinoni S; Tani M; Ferrarini I; Borella C; Varettoni M; Ibatici A; Motta M; Sanna A; Massaia M; Orsucci L; Quaresmini G; Vanazzi A; Vitale C; Reda G; Mauro FR; Laurenti L; Murru R; Visentin A; Frustaci AM; Sportoletti P; Deodato M;

The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells. in Frontiers in immunology / Front Immunol. 2023 Jan 16;13:1102471. doi: 10.3389/fimmu.2022.1102471. eCollection 2022.

2022
AO Cuneo

Massaia M; Giannotta C; Autino F;

Immune dysfunctions affecting bone marrow V?9V?2 T cells in multiple myeloma: Role of immune checkpoints and disease status. in Frontiers in immunology / Front Immunol. 2022 Dec 20;13:1073227. doi: 10.3389/fimmu.2022.1073227. eCollection 2022.

2022
AOU Città della Salute di Torino
AO Cuneo

Avonto I; Massaia M; Riganti C; Grasso M; Kopecka J; D'Agostino M; Larocca A; Tripoli E; Grimaldi D; Castella B; Giannotta C;

CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1. in Scientific reports / Sci Rep. 2021 Oct 27;11(1):21230. doi: 10.1038/s41598-021-00733-5.

2021
AO Cuneo
AOU Città della Salute di Torino

Funaro A; Ortolan E; Massaia M; Ferrero E; D'Ardia S; Marchisio S; Aydin S; Bracci C; Augeri S; Yakymiv Y;

Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment. in Medicina (Kaunas, Lithuania) / Medicina (Kaunas). 2021 Oct 14;57(10):1104. doi: 10.3390/medicina57101104.

2021
AO Cuneo

Massaia M; Rapezzi D; Castellino A; Santambrogio E;

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.

2021
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Bertù L; Pagano L; Corradini P; Musto P; Petrucci L; Zaja F; Grossi PA; Visani G; Lanza F; Cattaneo C; Mina R; La Barbera EO; Cardinali V; Galimberti S; Luppi M; Armiento D; Candoni A; Krampera M; Fracchiolla N; Bocchia M; Marchesi F; Tafuri A; Pinto A; Arcaini L; Ladetto M; Massaia M; Busca A; Venditti A; Romano I; et alii...

Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases. in Clinical case reports / Clin Case Rep. 2021 Jan 13;9(3):1066-1071. doi: 10.1002/ccr3.3593. eCollection 2021 Mar.

2021
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino

Rapezzi D; Zonta A; Priotto R; Masturzo B; Foglietta M; Mordini N; Mattei D; Celeghini I; Grosso E; Giacchello R; Signorile AF; Castellino C; Bonferroni M; Grasso M; Sorasio R; Castellino A; Elba S; Massaia M;

Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia. in British journal of haematology / Br J Haematol. 2020 Oct;191(1):e28-e32. doi: 10.1111/bjh.16960. Epub 2020 Jul 19.

2020
AO Cuneo
AOU Città della Salute di Torino

Bruno B; Ferrero D; Massaia M; Boccadoro M; Cattel F; Scaldaferri M; Faraci DG; Butera S; Martella F; Lia G; Olivi M; Cerrano M; Castella B; Giaccone L;

Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports. in Journal of medical case reports / J Med Case Rep. 2020 Jun 22;14(1):75. doi: 10.1186/s13256-020-02380-2.

2020
AO Cuneo

Massaia M; Fraternali Orcioni G; Giordano F; Grasso M; Celeghini I; Rapezzi D; Foglietta M; Mordini N; Drandi D; Strola G; Mattei D; Bonferroni M; Castellino C; Soriasio R; Castellino A; Elba S;

Metabolic approaches to rescue antitumor V?9V?2 T-cell functions in myeloma. in Frontiers in bioscience (Landmark edition) / Front Biosci (Landmark Ed). 2020 Jan 1;25(1):69-105. doi: 10.2741/4795.

2020
AO Cuneo

Massaia M; Castella B; Riganti C;

Anticancer innovative therapy: Highlights from the ninth annual meeting. in Cytokine & growth factor reviews / Cytokine Growth Factor Rev. 2020 Feb;51:1-9. doi: 10.1016/j.cytogfr.2019.12.002. Epub 2019 Dec 13.

2020
AO Cuneo

De Braud F; Del Vecchio M; Di Nicola M; Fortunato O; Anichini A; Dotti G; Massaia M; Pruneri G; Lisanti MP; Di Cosimo S; Wegner A; Pupa SM; Buschbeck M; De Santis F; Bracken AP; Volpari T;

Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance? in Seminars in cell & developmental biology / Semin Cell Dev Biol. 2020 Feb;98:80-89. doi: 10.1016/j.semcdb.2019.05.008. Epub 2019 May 18.

2020
AO Cuneo

Massaia M; Riganti C; Mungo E; Salaroglio IC; Castella B; Gazzano E; Kopecka J;

HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Boccadoro M; Gattei V; Foà R; Massaia M; Gaidano G; Zenz T; Bernardi R; Mauro FR; Laurenti L; Del Poeta G; Kodipad AA; Omedè P; Magliulo D; Rossi D; Marchetti M; Bonello L; Pozzato G; Bo MD; Kopecka J; Bomben R; Salvetti C; Riganti C; Todaro M; Vitale C; Griggio V; Coscia M;

Is it really an ordinary MGUS? A case of persistentimmunodepression in Italian Journal of Medicine

2020
ASL Cuneo 2
AO Cuneo

Rapezzi D; Giorgi R; Sappa M; Salomone F; Galli E; Grosso V; Massaia M; Pomero F; Campana S; Marinucci C;

Diagnosis of maternal Hodgkin lymphoma following abnormal findings at non invasive prenatal screening test (NIPT): Report of two cases in Haematologica

2019
AO Cuneo

Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Grasso M; Mattei D; Mordini N; Foglietta M; Mastruzo B; Priotto R; Zonta A; Rapezzi D; Massaia M;

IgM multiple myeloma and waldenstrom macroglobulinemia: Diagnostic challenges and therapeutic options. A report of two cases in Haematologica

2019
AO Cuneo

Elba S; Castellino A; Bonferroni M; Castellino C; Mattei D; Mordini N; Foglietta M; Priotto R; Rapezzi D; Sorasio R; Grasso M; Massaia M;

Increasing intratumor C/EBP-? LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2018 Nov 27;37(1):286. doi: 10.1186/s13046-018-0967-0.

2018
AO Cuneo

Kopecka J; Riganti C; Rubinstein M; Donadelli M; Abd-Elrahman GEFA; Massaia M; Castella B; Mungo E; Abdullrahman A; Salaroglio IC; Gazzano E;

V?9V?2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma. in Frontiers in oncology / Front Oncol. 2018 Nov 6;8:508. doi: 10.3389/fonc.2018.00508. eCollection 2018.

2018
AO Cuneo

Massaia M; Riganti C; Foglietta M; Castella B; Melaccio A;

V?9V?2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression. in Frontiers in immunology / Front Immunol. 2018 Jun 25;9:1492. doi: 10.3389/fimmu.2018.01492. eCollection 2018.

2018
AO Cuneo

Massaia M; Riganti C; Foglietta M; Castella B;

ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells. in Frontiers in immunology / Front Immunol. 2018 Jun 8;9:1246. doi: 10.3389/fimmu.2018.01246. eCollection 2018.

2018
AO Cuneo

Riganti C; Castella B; Massaia M;

Multifaceted immune checkpoint expression and senescent markers impairs bone marrow V?9V?2 T-cell function in multiple myeloma patients in Haematologica

2018
AO Cuneo

Castella B; Riganti C; Foglietta M; Tripoli E; Giannotta C; Massaia M;

ABCA1: an unexpected role in V?9V?2 T-cell activation by dendritic cells in Haematologica

2018
AO Cuneo

Massaia M; Riganti C; Foglietta M; Tripoli E; Castella B;

Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD(). in Oncoimmunology / Oncoimmunology. 2018 May 7;7(8):e1458809. doi: 10.1080/2162402X.2018.1458809. eCollection 2018.

2018
AO Cuneo

Pistoia V; Giuliani N; Malavasi F; Massaia M; Faini AC; Castella B; Toscani D; Costa F; Bolzoni M; Horenstein AL; Morandi F; Marimpietri D;

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. in Haematologica / Haematologica. 2017 Sep;102(9):e352-e355. doi: 10.3324/haematol.2016.156901. Epub 2017 Jun 8.

2017
AO Ordine Mauriziano
AOU Città della Salute di Torino
AO Cuneo

Piciocchi A; Boncompagni R; Orlando S; Cuneo A; Galieni P; Marasca R; Vannata B; Pozzato G; Efremov DG; Molica S; Coscia M; Massaia M; D'Arena G; Del Poeta G; Mannina D; Mauro FR; Ciolli S; Autore F; Innocenti I; Laurenti L; Vincelli D; Liberati AM; Russo F; Foá R;

A Score-Based Approach to (18)F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2017 Oct 26;7(4):57. doi: 10.3390/diagnostics7040057.

2017
AO Cuneo

Sambuceti G; Marini C; Bruzzi P; Gallamini A; Massaia M; Bellodi A; Arboscello E; Canepari ME; Spallarossa P; Sarocchi M; Nieri A; Piva R; Ferrarazzo G; Fiz F; Morbelli S; Bauckneht M;

The ATP-binding cassette transporter A1 regulates phosphoantigen release and V?9V?2 T cell activation by dendritic cells. in Nature communications / Nat Commun. 2017 Jun 5;8:15663. doi: 10.1038/ncomms15663.

2017
AO Cuneo
AOU Città della Salute di Torino

Massaia M; Riganti C; Novelli F; Caruso D; Mitro N; Foglietta M; Mandili G; Sciancalepore P; Castella B; Kopecka J;

A MRD-guided approach for the combination of ibrutinib to venetoclax in relapsed/refractory patients with chronic lymphocytic leukemia (improve study) in Hematological Oncology

2017
AO Cuneo
AOU Città della Salute di Torino

Ghia P; Scarfò L; Coscia M; Sancetta R; Ferrario A; Tedeschi A; Farina L; Laurenti L; Orlandi E; Reda G; Motta M; Carlo Stella C; Massaia M; Quaresmini G; Rossini F; Ladetto M; Gaidano G; Rossi V; Montillo M; Chiappella A; Carniti C; Ceccarelli M; Cabras MG; Re A; Salvi F; Santoro A; Stefoni V; Pileri S; Ciccone G; et alii...

Molecular pathways responsible for adaptive resistance to single-checkpoint inhibition may reveal biomarkers and immunotherapy targets in multiple myeloma patients in Blood

2017
AO Cuneo

Castella B; Foglietta M; Riganti C; Tripoli E; Boccadoro M; Massaia M;

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. in Haematologica / Haematologica. 2014 Sep;99(9):e159-61. doi: 10.3324/haematol.2014.106740. Epub 2014 Jun 27.

2014
AO Cuneo

Massaia M; Morra E; Nichelatti M; De Paoli L; Rossi D; Frustaci AM; Gallamini A; Motta M; Ghia P; Cascavilla N; Orlandi E; Petrizzi VB; Coscia M; Gaidano G; Tedeschi A; Montillo M;